ClinicalTrials.Veeva

Menu

Male breAsT cAncer preDisposition Factor (MATADOR)

I

Institut Claudius Regaud

Status

Completed

Conditions

Breast Cancer

Treatments

Other: Questionnaire completion

Study type

Observational

Funder types

Other

Identifiers

NCT06219187
23 SEIN 02

Details and patient eligibility

About

This is a non-interventional, prospective, single-center study designed to collect and describe environmental and psychosocial data from patients with a history of male breast cancer (MBC) referenced in the IUCT-O regional database.

The study will be conducted on a population of 110 to 150 patients.

Enrollment

93 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male patient with a personal history of breast cancer
  2. Age ≥ 18 years
  3. Patient who has had an oncogenetic consultation at IUCT-O and is registered in the IUCT-O oncogenetic database
  4. Patient for whom no pathogenic variant has been detected on the HBOC panel (HBOC-)
  5. Patient with no objection to participation in the trial (for deceased patients: trusted support person with no objection to participation).

Exclusion criteria

  1. Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).

Trial design

93 participants in 1 patient group

Male breast cancer
Treatment:
Other: Questionnaire completion

Trial contacts and locations

1

Loading...

Central trial contact

Christine TOULAS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems